<DOC>
	<DOCNO>NCT01121653</DOCNO>
	<brief_summary>Use lay language . The aim study evaluate pain score ( neuropathic pain questionnaire pain numeric scale ) quality life , effect oral magnesium intake patient neuropathic pain compare patient receive placebo , . The study drug take 4 week .</brief_summary>
	<brief_title>Impact Oral Magnesium Neuropathic Pain</brief_title>
	<detailed_description>Protocol description Visit D0 - patient inclusion inform sign consent - clinical exam - blood sampling ( magnesium dosage ) - questionnaire ( neuropathic pain quality life ) - daily self-evaluation neuropathic pain scale ( Week0 Week5 ) D8 : first intake study drug ( magnesium placebo ) Visit Week5 : - questionnaire ( neuropathic pain quality life ) - blood sampling ( magnesium dosage ) - clinical exam</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>neuropathic pain inform sign consent magnesium intake contraindication severe renal insufficiency quinidine intake concomitant treatment change 2weeks inclusion evolutive pathology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Neuropathic pain , magnesium</keyword>
</DOC>